Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and β-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 11, 2003, Pages 5090-5098

  Maldonado, Mario ^a,b   Hampe, Christiane S ^c   Gaur, Lakshmi K ^c,d   D'Amico, Susana ^a   Iyer, Dinakar ^a   Hammerle, Lisa P ^c   Bolgiano, Douglas ^d   Rodriguez, Lucille ^b   Rajan, Arun ^a   Lernmark, Åke ^c   Balasubramanyam, Ashok ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; HLA ANTIGEN CLASS 2; IA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; B LYMPHOCYTE; BODY MASS; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; EVALUATION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENETICS; LONGITUDINAL STUDY; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOMES RESEARCH; PARAMETER; PATIENT; PATIENT CODING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYNDROME;

ADOLESCENT; ADULT; AUTOANTIBODIES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY TESTING; HUMANS; ISLETS OF LANGERHANS; ISOENZYMES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 10744227156     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030180     Document Type: Article

References (70)

1. Foster DW 1998 Diabetes mellitus. In: Fauci AS, Braunwald E, Isselbacher KJ, eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill; 2060-2080
2. Orland M 1998 Diabetes mellitus. In: Ewald G, McKenzie C, eds. Manual of medical therapeutics. 29th ed. Boston: Little, Brown
3. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP 1987 Maturity-onset diabetes of youth in black Americans. N Engl J Med 316:285-291
4. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V 1999 New profiles of diabetic ketoacidosis: type 1 vs. type 2 diabetes and the effect of ethnicity. Arch Intern Med 159:2317-2322
5. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE 1994 GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 43:741-745
6. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, Nepom GT, Clark WS, Mixon PS, Kitabchi AE 1999 Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 22:1517-1523
7. Umpieriez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS 1995 Diabetic ketoacidosis in obese African-Americans. Diabetes 44:790-795
8. Westphal SA 1996 The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med 101:19-24
9. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM 2001 Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131-153
10. Sobngwi E, Gautier JF 2002 Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia 45:283-285
11. American Diabetes Association 2002 Standards of medical care for patients with diabetes mellitus. Diabetes Care 25:S33-S48
12. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A 1994 A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350
13. Falorni A, Ortqvist E, Persson B, Lernmark A 1995 Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods 186:89-99
14. Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Torn C, Persson B, Lernmark A 2000 Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J Clin Endocrinol Metab 85:4671-4679
15. Mire-Sluis AR, Gaines Das R, Lernmark A 2000 The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 43:1282-1292
16. Leech NJ, Kitabchi AE, Gaur LK, Hagopian WA, Hansen J, Burghen GA, Palmer JP, Nepom GT 1995 Genetic and immunological markers of insulin-dependent diabetes in black Americans. Autoimmunity 22:27-32
17. Hother-Nielsen O, Faber O, Sorensen NS, Beck-Nielsen H 1988 Classification of newly diagnosed diabetic patients as insulin-requiring or noninsulin-requiring based on clinical and biochemical variables. Diabetes Care 11:531-537
18. Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppala P 1985 C-peptide determination in the choice of treatment in diabetes mellitus. Scand J Clin Lab Invest 45:589-597
19. Erlich HA, Griffith RL, Bugawan TL, Ziegler R, Alper C, Eisenbarth G 1991 Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes 40:478-481
20. Cucca F, Muntoni F, Lampis R, Frau F, Argiolas L, Silvetti M, Angius E, Cao A, De Virgiliis S, Congia M 1993 Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 37:85-94
21. Hu CY, Allen M, Chuang LM, Lin BJ, Gyllensten U 1993 Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum Immunol 38:105-114
22. Agardh D, Gaur LK, Agardh E, Landin-Olsson M, Agardh CD, Lernmark A 1996 HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia 39:1313-1317
23. Greenbaum CJ, Gaur LK, Noble JA 2002 ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types. J Autoimmun 18:67-70
24. Todd JA, Bell JI, McDevitt HO 1987 HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604
25. Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH 1988 Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia 31:864-870
26. Michelsen B, Wassmuth R, Ludvigsson J, Lernmark A, Nepom GT, Fisher L 1990 HLA heterozygosity in insulin-dependent diabetes is most frequent at the DQ locus. Scand J Immunol 31:405-413
27. Mijovic CH, Jenkins D, Jacobs KH, Penny MA, Fletcher JA, Barnett AH 1991 HLA-DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a black population. Diabetes 40:748-753
28. Sanjeevi CB, Zeidler A, Shaw S, Rotter J, Nepom GT, Costin G, Raffel L, Eastman S, Kockum I, Wassmuth R, et al. 1993 Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitus. Tissue Antigens 42:72-77
29. Thorsby E, Konningen KS 1993 Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377
30. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK 1993 Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry. Diabetologia 36:1155-1162
31. Ronningen KS, Spurkland A, Tait BD, Drummond B, Lopez-Larrea C, Baranda FS 1991 HLA Class II association in insulin-dependent diabetes mellitus among Blacks, Caucasoids and Japanese. In: Tsuji K, Aizawa M, Sasasuki T, eds. HLA 1991: Proceedings of the 11th International Histocompatibility Workshop and Conference, Yokohama, Japan, 1991, pp 713-722
32. Heimberg H, Nagy ZP, Somers G, De Leeuw I, Schuit FC 1992 Complementation of HLA-DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum Immunol 33:10-17
33. Cavan DA, Jacobs KH, Penny MA, Kelly MA, Mijovic C, Jenkins D, Fletcher JA, Barnett AH 1993 Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia 36:252-257
34. Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A 1995 Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls. Eur J Immunogenet 22:443-465
35. Pugliese A, Gianani R, Moromisato R, Awdeh ZL, Alper CA, Erlich HA, Jackson RA, Eisenbarth GS 1995 HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 44:608-613
36. Patel SD, Cope AP, Congia M, Chen TT, Kim E, Fugger L, Wherrett D, Sonderstrup-McDevitt G 1997 Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101, beta1*0401) transgenic mice. Proc Natl Acad Sci USA 94:8082-8087
37. Horn GT, Bugawan TL, Long CM, Erlich HA 1988 Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci USA 85:6012-6016
38. Borg H, Marcus C, Sjoblad S, Fernlund P, Sundkvist G 2000 Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes. Acta Paediatr 89:46-51
39. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A 1993 HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 53:150-167
40. Marincola FM, Stroncek D, Simonis T 1997 Caucasian vs. normal In: Terasaki P, Gjertson D, eds. HLA 1997. Los Angeles: Tissue Typing Laboratory; 348-349
41. American Diabetes Association 2002 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 25:S5-S20
42. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC 1999 Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157
43. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R 1997 UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective diabetes study group. Lancet 350:1288-1293
44. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A 1993 Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374
45. Pozzilli P, Di Mario U 2001 Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 24:1460-1467
46. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR 1993 Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362
47. Bingley PJ, Bonifacio E, Gale EA 1993 Can we really predict IDDM? Diabetes 42:213-220
48. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A 2001 β-Cell adaptation and decompensation during the progression of diabetes. Diabetes 50(Suppl 1):S154-S159
49. Robertson RP, Olson LK, Zhang HJ 1994 Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 43: 1085-1089
50. Eizirik DL, Korbutt GS, Hellerstrom C 1992 Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J Clin Invest 90:1263-1268
51. Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM 2001 The role of lipids in the pathogenesis of muscle insulin resistance and β cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes 109:S189-S201
52. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P 2001 Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care 24:1014-1018
53. Porte Jr D, Kahn SE 2001 β-Cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 50(Suppl 1):S160-S163
54. Polonsky KS, Sturis J, Bell GI 1996 Seminars in medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the βcell to compensate for insulin resistance. N Engl J Med 334:777-783
55. Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S 2001 Role of apoptosis in pancreatic β-cell death in diabetes. Diabetes 50(Suppl 1):S44-S47
56. Melato M, Antonutto G, Ferronato E 1977 Amyloidosis of the islets of Langerhans in relation to diabetes mellitus and aging. Beitr Pathol 160:73-81
57. Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K 1998 Relation between iron stores and non-insulin-dependent diabetes in men: case-control study. BMJ 317:727
58. Bohme J, Carlsson B, Wallin J, Moller E, Persson B, Peterson PA, Rask L 1986 Only one DQ-β restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol 137:941-947
59. Bao MZ, Wang JX, Dorman JS, Trucco M 1989 HLA-DQ β nonASP-57 allele and incidence of diabetes in China and the USA. Lancet 2:497-498
60. Owerbach D, Gunn S, Gabbay KH 1989 Primary association of HLA-DQw8 with type I diabetes in DR4 patients. Diabetes 38:942-945
61. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD 1990 Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836-1841
62. Khalil I, d'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, Hors J 1990 A combination of HLA-DQ β Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85:1315-1319
63. Ivarsson SA, Eriksson S, Kockum I, Lernmark A, Lindgren S, Nilsson KO, Sundkvist G, Wassmuth R1993 HLA-DR3, DQ2 homozygosity in two patients with insulin-dependent diabetes mellitus superimposed with ulcerative colitis and primary sclerosing cholangitis. J Intern Med 233:281-286
64. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G 2002 Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 51:1346-1355
65. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonsky KS 1996 Maturity onset diabetes of the young (MODY). Diabet Med 13:S90-S95
66. Maassen JA 2002 Mitochondrial diabetes: pathophysiology, clinical presentation, and genetic analysis. Am J Med Genet 115:66-70
67. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y 2000 A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM study group. N Engl J Med 342: 301-307
68. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y, Okuyama M, Juji T 1990 High frequency of aspartic acid at position 57 of HLA-DQ β-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes 39:266-269
69. Yamagata K, Nakajima H, Hanafusa T, Noguchi T, Miyazaki A, Miyagawa J, Sada M, Amemiya H, Tanaka T, Kono N, Tarui S 1989 Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 32:762-764
70. Lernmark A 2000 Rapid-onset type 1 diabetes with pancreatic exocrine dysfunction. N Engl J Med 342:344-345